Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of 34.20% and 16.18%, respectively, for the quarter ended March 2025. Do…
0,580$
-2,52%
Echtzeit-Aktienkurs Karyopharm Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Karyopharm Therapeutics Inc. Aktie
Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of 7.69% and 0.83%, respectively, for the quarter ended December 2024. Do…
Karyopharm Therapeutics Inc. (KPTI) Q3 2024 Earnings Call Transcript
…
Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript
KPTI earnings call for the period ending September 30, 2024.…
Karyopharm Therapeutics Inc. (KPTI) Q2 2024 Earnings Call Transcript
…
Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript
KPTI earnings call for the period ending June 30, 2024.…
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
KPTI earnings call for the period ending March 31, 2024.…
Karyopharm Therapeutics Inc. (KPTI) Q1 2024 Earnings Call Transcript
…
Karyopharm Therapeutics Q1 2024 Earnings Preview
…
Karyopharm Therapeutics: Spiraling Despite Upcoming Catalysts
…
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
KPTI earnings call for the period ending December 31, 2023.…
Karyopharm Therapeutics Inc. (KPTI) Q4 2023 Earnings Call Transcript
…